Azelaic Acid on Demodex Counts in Rosacea

Inclusion Criteria: * Male and female subjects, ages 18 and over, with mild to moderate paulopustular rosacea with bilateral facila involvement, who agrees to participate and provide written consent. * Positive Demodex folliculorum SSSB, defined as \>5 mites/cm on at least on of two different SSSB specimens on bilateral sides of teh face. * Have an IGA of mild to moderate rosacea, rating between 2 and 5. Exclusion Criteria: * Use of topical therapy for rosacea or other skin conditions on the face within two weeks of Baseline. * Use of oral medications for the treatment of rosacea that have been started or altered within the past three months. * Presence of a concurrent medical condition or skin condition, which is determined by the investigator to potentially interfere with study outcomes or patient assessments. * Subjects with known allergy or sensitivity to azelaic acid gel or components therein, such as propylene glycol. * Subjects with known allergy or sensitivity to cyanoacrylates or formaldehyde. * Presence of more than two nodules. * Female subjects who are not postmenopausal for at least 1 year, surgically sterile or willing to practice effective contraception during the study. Reliable methods of birth control are: abstinence, oral contraceptives, intrauterine device, DepoProvera, tubal ligation or vasectomy of the partner in a monogamous relationship. An acceptable, though less reliable, method involves the careful use of condoms and spermicidal foam or gel and/or a cervical cap or sponge. Nursing mothers, pregnant women and women planning to become pregnant while on study are to be excluded.